Dihydroorotate dehydrogenase
Dihydroorotate dehydrogenase
Dihydroorotate dehydrogenase (DHODH) is an enzyme that plays a crucial role in the de novo synthesis of pyrimidines. It catalyzes the fourth step in the pyrimidine biosynthesis pathway, which is the conversion of dihydroorotate to orotate. This reaction is essential for the production of uridine monophosphate (UMP), a precursor for all pyrimidine nucleotides.
Function
DHODH is a flavoprotein that uses flavin mononucleotide (FMN) as a cofactor. The enzyme is located in the inner mitochondrial membrane in eukaryotes and in the cytoplasm of prokaryotes. The reaction catalyzed by DHODH involves the oxidation of dihydroorotate to orotate, with the concomitant reduction of quinone to quinol in eukaryotes or the reduction of NAD+ to NADH in prokaryotes.
Structure
The structure of DHODH varies between species. In humans, DHODH is a monomeric enzyme composed of a single polypeptide chain. The active site of the enzyme contains a binding pocket for dihydroorotate and FMN. The enzyme also has a hydrophobic domain that anchors it to the inner mitochondrial membrane.
Clinical Significance
DHODH is a target for several immunosuppressive and antiproliferative drugs. Inhibitors of DHODH, such as leflunomide and teriflunomide, are used in the treatment of rheumatoid arthritis and multiple sclerosis, respectively. These drugs work by depleting pyrimidine pools, which inhibits the proliferation of rapidly dividing cells, including lymphocytes.
Genetic Disorders
Mutations in the DHODH gene can lead to Miller syndrome, a rare genetic disorder characterized by craniofacial abnormalities and limb defects. This condition is inherited in an autosomal recessive manner.
Research Applications
DHODH is studied extensively in the context of cancer and infectious diseases. Inhibitors of DHODH are being investigated as potential treatments for various types of cancer, as well as for malaria and viral infections.
See Also
References
External Links
Lua error in package.lua at line 80: module 'strict' not found.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD